Immune-related adverse events are clustered into distinct subtypes by T-cell profiling before and early after anti-PD-1 treatment

Although anti-programmed death-1 (PD-1) treatment has shown remarkable anti-tumor efficacy, immune-related adverse events (irAEs) develop with heterogeneous clinical manifestations. However, the immunological understanding of irAEs is currently limited. In the present study, we analyzed peripheral b...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyung Hwan, Hur, Joon Young, Cho, Jinhyun, Ku, Bo Mi, Koh, Jiae, Koh, June Young, Sun, Jong-Mu, Lee, Se-Hoon, Ahn, Jin Seok, Park, Keunchil, Ahn, Myung-Ju, Shin, Eui-Cheol
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999841/
https://www.ncbi.nlm.nih.gov/pubmed/32076579
http://dx.doi.org/10.1080/2162402X.2020.1722023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6999841/
https://www.ncbi.nlm.nih.gov/pubmed/32076579
http://dx.doi.org/10.1080/2162402X.2020.1722023

Ejemplares similares